Everand Logo

Welcome to Everand!

  • Discover this podcast and so much more

    Podcasts are free to enjoy without a subscription. We also offer ebooks, audiobooks, and so much more for just $11.99/month.

    The future of radiotheranostics

    The future of radiotheranostics

    FromThe Lancet Oncology in conversation with

    Start listeningView podcast show

    The future of radiotheranostics

    FromThe Lancet Oncology in conversation with

    ratings:
    Length:
    8 minutes
    Released:
    Mar 11, 2020
    Format:
    Podcast episode

    Description

    Ken Herrman (University Hospital Essen, Essen, Germany) discusses a Review in The Lancet Oncology on the role of injectable radiopharmaceuticals with anti-tumour effects.Continue this conversation on social!Follow us today at...https://twitter.com/thelancet & https://Twitter.com/TheLancetOncolhttps://instagram.com/thelancetgrouphttps://facebook.com/thelancetmedicaljournalhttps://linkedIn.com/company/the-lancethttps://youtube.com/thelancettv
    Released:
    Mar 11, 2020
    Format:
    Podcast episode

    Titles in the series (100)

    Editors of The Lancet Oncology and the journal’s authors explore their research and its impact on people’s health, health care, and health policy in this regular podcast.